Table of Contents Table of Contents
Previous Page  S181 S290 Next Page
Information
Show Menu
Previous Page S181 S290 Next Page
Page Background

Poster 150:

Identifying Risk Factors for Acute Care Transfer

During Inpatient Rehabilitation

Cameron J. Collier, MD (University of Texas Southwestern, Dallas, TX,

United States), Benjamin Shahabi-Azad, MD

Disclosures:

Cameron J. Collier: I Have No Relevant Financial Re-

lationships To Disclose

Objective:

To identify clinical variables present on admission to

inpatient rehabilitation (IPR) that may indicate risk for transfer to

acute care services.

Design:

Case-control study.

Setting:

A 36-bed inpatient rehabilitation unit.

Participants:

862 patients admitted between July 1st 2015 - June 30th

2016 and subsequently discharged to community (control group) or

acutely transferred (case group).

Interventions:

Not applicable.

Main Outcome Measures:

Age, admission Functional Independence

Measures (FIM) score, date of admission, and length of stay were

available for both groups. Clinical variables including laboratory data,

vitals, blood product given within previous 72 hours, intravenous, oral,

and intramuscular antibiotics, and pressure ulcers present on admis-

sion were collected by chart review within the acute transfer group.

Results:

Descriptive statistics and logistic regression using XLSTAT

software was used for data analysis. Of 862 patients admitted to IPR,

733 (85.0%) were discharged to community, and 129 (14.9%) were

transferred to acute care. Admission FIM scores were a predictor for

acute transfer (p

<

.0001, OR 1.02). The most common diagnosis

prompting transfer to acute care was sepsis (86%) and respiratory

failure (13%). In subgroup analysis of acute transfers, 13% had received

blood product within 72 hours prior to admission, 31% had pressure

ulcers on admission, and 35% were receiving IV antibiotics on admission

to IPR. Receiving IV antibiotics was predictive of acute transfer within

72 hours of admission (p

¼

.017, OR 3.42).

Conclusions:

Among the patients admitted to IPR, lower admission

FIM scores were statistically significant but a weak predictor of acute

transfer when compared to control. Within the control group,

receiving IV antibiotics on admission was predictive of transfer within

72 hours. This suggests that clinical variables on admission may help

identify patients at risk for medical complications and acute transfer

during IPR.

Level of Evidence:

Level III

Poster 151:

Comparing Opioid & Benzodiazepine use in Acute

Inpatient Rehabilitation: A Quality Improvement

Project

Stacey A. Bennis, MD (McGaw MC of NW Univ NW Med Schl/RIC),

Kristen T. McCormick, DO, MS, Chris Butler, PharmD, BCPS,

James W. Atchison, DO, FAAPMR

Disclosures:

Stacey Bennis: I Have No Relevant Financial Relationships

To Disclose

Objective:

To assess concomitant usage opioid and benzodiazepine

medications (scheduled and/or as-needed) among patients in an acute

inpatient rehabilitation facility setting at the time of admission

compared to the time of discharge.

Design:

Retrospective Cohort Study.

Setting:

Acute Inpatient Rehabilitation Facility (AIRF).

Participants:

All patients above the age of 18 years old admitted to an

academic AIRF between 2/1/16 and 3/31/16 (n

¼

439) were included in

the study. Patients with chronic implanted pain pumps were excluded.

Interventions:

Not applicable.

Main Outcome Measures:

The primary outcome measure was to

determine the percent reduction in combined opioid/benzodiazepine

use from admission to discharge. Secondary outcome measures

included percent reduction in opioid usage from admission to

discharge, percent reduction in benzodiazepine usage from admission

to discharge, and reduction in moderate/high daily Morphine Milligram

Equivalents (MME) dosages from admission to discharge (defined as

>

50MME/day by the CDC “Guideline for Prescribing Opioids for Chronic

Pain”.

Results:

Of the 439 patients analyzed, 149 were admitted on opioids

(33.9%), 80 on benzodiazepines (18.2%), and 57 patients (13.0% of all

patients, 38.3% in the opioid subgroup) were being treated with

combined opioid/benzodiazepine therapy. At time of admission, 73

patients (16.6%) were on “unsafe” daily MME dosages (

>

50 MME/day)

as defined by the CDC guidelines. At the time of discharge, 19 patients

remained on dual opioid/benzodiazepine therapy (67% reduction), 112

patients remained on opioid monotherapy (25% reduction), and 43

patients remained on benzodiazepine monotherapy (46% reduction).

At the time of discharge, 45 patients (10.3% overall, 6.3% reduction)

were on “unsafe” daily MME dosages.

Conclusions:

This retrospective cohort study demonstrates trends for

a reduction in concomitant opioid/benzodiazepine use (67%), reduc-

tion in opioid and benzodiazepine monotherapy (25% and 46%,

respectively), and reduction in “unsafe” daily MME dosages (6.3%).

Inpatient physiatrists appear to be reducing concomitant opioid/

benzodiazepine use, benzodiazepine & opioid monotherapy treat-

ments, with a goal of reduce daily MME requirements.

Level of Evidence:

Level IV

Poster 152:

Improving Fall Rates Below the National Average in an

Acute Rehabilitation Hospital Using Modified

Screening Tools: A Retrospective Analysis

Raman Sharma, MD (Burke Rehabilitation Hospital, White Plains, NY,

United States), Marie Spencer, PhD, RN, CRRN, Barry Jordan, MD,

MPH, Karen M. Pechman, MD, Anne F. Ambrose, MD

Disclosures:

Raman Sharma, MD: I Have No Relevant Financial Re-

lationships To Disclose

Objective:

Hospital-related falls are a major cause of additional pain

and suffering, morbidity, mortality, length-of-stay and cost. At this

150-bed free-standing acute rehabilitation hospital, intense multi-

disciplinary efforts have reduced the fall rate significantly over the

past 5 years to below the national average. In this retrospective study

we sought to understand the factors responsible for the improvement.

Our hypothesis is that the modifications made to the screening tool

making it more sensitive, thus allowing more timely interventions has

been the major factor in driving the change.

Design:

This is a retrospective chart review of all admissions from

2011 to 2015. Data analysis was also done using information gathered

with E-Rehab tool. Information collected included patient de-

mographics, admission diagnosis, medical co-morbidities, functional

status, fall screening tools, data collection and analysis methods. Fall

related details were obtained from incident reports. IRB approval was

obtained.

Setting:

The setting is a 150-bed free-standing acute rehabilitation

hospital.

Participants:

All inpatient units (SCI, TBI, Stroke, Ortho, CardioPulm).

Interventions:

Modifications to screening tools to include fall-related

medications, seizures, confusion, movement disorders and orthostatic

hypotension.

Main Outcome Measures:

Falls reports.

Results:

Falls were defined using the standard AGS criteria. In 2011,

patient demographics were similar to national data (2011 CMI- 1.2088;

National CMI- 1.2784): fall rate was 5.43% (NDNQI participating hos-

pitals- 6.13%). At this time, Burke utilized the Hendrich II Fall Risk

Model, a standard tool used in most hospitals. In 2015, the patient

Burke CMI was 1.3099 (National- 1.3169). However our fall rate fell to

3.1% (NDNQI hospitals- 4.1%).

S181

Abstracts / PM R 9 (2017) S131-S290